Research map: 2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism
Back to the article
Papers in this map
Tissue-based map of the human proteome
· Mathias Uhlén · 2015 · 16361 citations · Cited by this paper
Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia
· 2026 · Related
Hallmarks of Cancer: New Dimensions
· Douglas Hanahan · 2022 · 9836 citations · Cited by this paper
Tailoring pH-responsive charge-conversional interfaces in ionizable lipid-based nanoliposomes for synchronized co-delivery and synergistic therapy of triple-negative breast cancer
· 2026 · Related
Understanding the Intersections between Metabolism and Cancer Biology
· Matthew G. Vander Heiden · 2017 · 2477 citations · Cited by this paper
Preserved motor function and prolonged sensory local anesthesia with novel PLGA microparticles co-encapsulating lidocaine and capsaicin
· 2026 · Related
Cellular response to oxidative stress: Signaling for suicide and survival*
· Jennifer L. Martindale · 2002 · 2323 citations · Cited by this paper
Iron–quercetin complex induces ex vivo proteomic remodeling in circulating proangiogenic cells derived from human peripheral blood mononuclear cells
· 2026 · Related
Cancer metabolism: a therapeutic perspective
· Ubaldo Martinez‐Outschoorn · 2016 · 1531 citations · Cited by this paper
Acetonic extract of Saskatoon berry attenuates amyloid-associated neurotoxicity in cellular and Drosophila melanogaster Alzheimer’s disease models
· 2026 · Related
The pentose phosphate pathway and cancer
· Krushna Chandra Patra · 2014 · 1471 citations · Cited by this paper
Design of sunflower trypsin inhibitor 1 derived probes targeting the LDLR and evaluation of their brain delivery
· 2026 · Related
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
· Lukas Franz Mager · 2020 · 1415 citations · Cited by this paper
The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts
· 2026 · Related
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
· Yoichiro Mitsuishi · 2012 · 1409 citations · Cited by this paper
Urinary biomarkers in muscle-invasive bladder cancer: Current state and open opportunities for neoadjuvant chemotherapy response prediction and patient stratification
· 2026 · Related
p53 and metabolism
· Karen H. Vousden · 2009 · 974 citations · Cited by this paper
Fluorinated isoindolinone–amino acid hybrids possessing antiproliferative and antitumor activity in vitro and in vivo
· 2026 · Related
Regulation of PTEN Transcription by p53
· Vuk Stambolic · 2001 · 924 citations · Cited by this paper
O-GlcNAc transferase as an oncogenic regulator in hematologic malignancies: Mechanisms, disease contexts, and therapeutic perspectives
· 2026 · Related
Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
· Krushna Chandra Patra · 2013 · 882 citations · Cited by this paper
BRENDA, the ELIXIR core data resource in 2021: new developments and updates
· Antje Chang · 2020 · 851 citations · Cited by this paper
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
· Peng Jiang · 2011 · 825 citations · Cited by this paper
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
· Amparo Wolf · 2011 · 817 citations · Cited by this paper
Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
· Fuyuki Ishikawa · 1989 · 715 citations · Cited by this paper
Metabolic programming and immune suppression in the tumor microenvironment
· Emily Nicole Arner · 2023 · 678 citations · Cited by this paper
The pentose phosphate pathway in health and disease
· Tara A. TeSlaa · 2023 · 653 citations · Cited by this paper
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
· Muhammad Tufail · 2024 · 516 citations · Cited by this paper
Purine nucleoside phosphorylases: properties, functions, and clinical aspects
· Agnieszka Bzowska · 2000 · 500 citations · Cited by this paper
Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies
· Yimon Aye · 2014 · 456 citations · Cited by this paper
Regulation of cancer cell metabolism: oncogenic MYC in the driver’s seat
· Yang Dong · 2020 · 413 citations · Cited by this paper
Thymidine phosphorylase is angiogenic and promotes tumor growth.
· Amir Moghaddam · 1995 · 393 citations · Cited by this paper
Angiogenic activity of enzymes
· Misako Haraguchi · 1994 · 350 citations · Cited by this paper
Nonenzymatic Glycosylation, the Maillard Reaction and the Aging Process
· Vincent M. Monnier · 1990 · 342 citations · Cited by this paper
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction
· Tingting Wang · 2020 · 340 citations · Cited by this paper
What is cancer metabolism?
· Lydia W.S. Finley · 2023 · 336 citations · Cited by this paper
Angiogenic factor
· Tatsuhiko Furukawa · 1992 · 309 citations · Cited by this paper
Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer
· John T. Cunningham · 2014 · 272 citations · Cited by this paper
Emerging therapies in cancer metabolism
· Yi Xiao · 2023 · 258 citations · Cited by this paper
Source: OpenAlex (CC0)